Gendell Jeffrey L Fennec Pharmaceuticals Inc. Transaction History

Gendell Jeffrey L

$5.22 Billion
Q3 2025

A detailed history of Gendell Jeffrey L transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Gendell Jeffrey L holds 139,559 shares of FENC stock, worth $1.13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

139,559

Previous 139,706 0.11%

Holding current value

$1.13 Million

Previous $1.16 Million 10.7%

% of portfolio

0.02%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$7.84 - $9.24 $1,152 - $1,358	-147 Reduced 0.11%	139,559 $1.28 Million
Q2 2025 Aug 14, 2025	SELL	$5.01 - $8.4 $278,130 - $466,326	-55,515 Reduced 28.44%	139,706 $1.16 Million
Q1 2025 May 15, 2025	SELL	$5.54 - $7.02 $22,459 - $28,459	-4,054 Reduced 2.03%	195,221 $1.19 Million
Q4 2024 Feb 14, 2025	SELL	$3.99 - $6.37 $129,938 - $207,445	-32,566 Reduced 14.05%	199,275 $1.26 Million
Q3 2024 Nov 14, 2024	SELL	$4.85 - $6.73 $249,891 - $346,756	-51,524 Reduced 18.18%	231,841 $1.16 Million
Q2 2024 Aug 14, 2024	SELL	$6.02 - $10.99 $115,060 - $210,051	-19,113 Reduced 6.32%	283,365 $1.73 Million
Q1 2024 May 15, 2024	BUY	$8.82 - $11.12 $176,400 - $222,399	20,000 Added 7.08%	302,478 $3.36 Million
Q4 2023 Feb 14, 2024	SELL	$6.48 - $11.61 $22,770 - $40,797	-3,514 Reduced 1.23%	282,478 $3.17 Million
Q3 2023 Nov 13, 2023	BUY	$7.15 - $8.94 $18,439 - $23,056	2,579 Added 0.91%	285,992 $2.15 Million
Q2 2023 Aug 11, 2023	BUY	$7.27 - $9.82 $226,293 - $305,667	31,127 Added 12.34%	283,413 $2.5 Million
Q1 2023 May 12, 2023	BUY	$7.38 - $10.35 $732,214 - $1.03 Million	99,216 Added 64.82%	252,286 $2.1 Million
Q4 2022 Feb 13, 2023	BUY	$7.63 - $10.22 $1.17 Million - $1.56 Million	153,070 New	153,070 $1.47 Million

Others Institutions Holding FENC

# of Institutions

Shares Held

14.2M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $211M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gendell Jeffrey L, based on Form 13F filings with the SEC.

News

Stay updated on Gendell Jeffrey L with notifications on news.

Account

Gendell Jeffrey L Fennec Pharmaceuticals Inc. Transaction History